Literature DB >> 24876580

Differences in Glycemic Variability Between Normoglycemic and Prediabetic Subjects.

Markolf Hanefeld1, Stefan Sulk2, Matthias Helbig2, Andreas Thomas3, Carsta Köhler2.   

Abstract

So far the criteria for NGT and abnormal glucose tolerance (AGT) are based on HbA1c and 75 g oGTT. We present data on GV and diurnal profiles in stratified cohorts with AGT versus controls. 28 NGT, 42 AGT (15 IGT, 11 IFG, 16 CGI) matched for age and BMI classified by 75 g oGTT underwent a CGM with test meal (TM). Diurnal profiles, glucose excursion after TM, and GV (SD, MAGE) were calculated for day 2 and 3. HbA1c, with its values of 5.5 ± 0.37% versus 5.65 ± 0.36%, was within normal range. Average interstitial glucose (AiG) was 5.84 ± 0.52 mmol/l) in NGT and 6.35 ± 0.65 mmol/l in AGT (P = .002). The 2 h incremental area under curve (iAUC) from TM until 2 h after TM was 1.94 ± 1.31 mmol/l*h versus 2.89 ( ± 1.75) mmol/l*h (P = .012), AiG 2 hours after TM was 5.99 ± 1.14 mmol/l*d versus 6.64 ± 1.30 mmol/l (P = .035). Peaks of AiG after TM were 7.69 ± 1.48 mmol/l*d versus 9.18 ± 1.67 mmol/l*d (P = .001). SD was significantly higher for AGT (1.12 ± 0.37 vs. 0.85 ± 0.32 mmol/l, P = .01) and MAGE 2.26 ± 0.84 vs. 1.60 ± 0.69 mmol/l, P = .005). In this comparative analysis NGT and AGT well matched for age, BMI, and comorbidities, CGM revealed significant differences in daytime AiG, pp glucose excursion and postprandial peaks. SD and MAGE was significantly higher for subjects with AGT. I Impaired glucose homeostasis a better characterizes degree of AGTe than HbA1c and 75 g OGTT.
© 2014 Diabetes Technology Society.

Entities:  

Keywords:  HbA1c; continuous glucose monitoring; glucose homeostasis; glycemic variability; normal glucose tolerance; prediabetes

Year:  2014        PMID: 24876580      PMCID: PMC4455406          DOI: 10.1177/1932296814522739

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  18 in total

Review 1.  Continuous glucose monitoring: roadmap for 21st century diabetes therapy.

Authors:  David C Klonoff
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

2.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

3.  Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes.

Authors:  M Hanefeld; C Koehler; C Hoffmann; K Wilhelm; W Kamke; H Gerstein
Journal:  Diabet Med       Date:  2010-02       Impact factor: 4.359

4.  Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups.

Authors:  Nathan R Hill; Nick S Oliver; Pratik Choudhary; Jonathan C Levy; Peter Hindmarsh; David R Matthews
Journal:  Diabetes Technol Ther       Date:  2011-06-29       Impact factor: 6.118

5.  Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus.

Authors:  B Engler; C Koehler; C Hoffmann; W Landgraf; S Bilz; C Schoner; S R Bornstein; M Hanefeld
Journal:  Exp Clin Endocrinol Diabetes       Date:  2011-01-18       Impact factor: 2.949

6.  Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Risk Factors in Impaired Glucose Tolerance for Atherosclerosis and Diabetes.

Authors:  M Hanefeld; C Koehler; E Henkel; K Fuecker; F Schaper; T Temelkova-Kurktschiev
Journal:  Diabet Med       Date:  2000-12       Impact factor: 4.359

7.  Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis.

Authors:  Roger S Mazze; Ellie Strock; David Wesley; Sarah Borgman; Blaine Morgan; Richard Bergenstal; Robert Cuddihy
Journal:  Diabetes Technol Ther       Date:  2008-06       Impact factor: 6.118

8.  Glycemic variability: should we and can we prevent it?

Authors:  Louis Monnier; Claude Colette
Journal:  Diabetes Care       Date:  2008-02       Impact factor: 19.112

9.  Relevance of casual undetected hyperglycemia among high-risk individuals for developing diabetes.

Authors:  Bernardo Costa; Jesús Vizcaíno; Josep Lluís Piñol; Joan Josep Cabré; Cruz María Fuentes
Journal:  Diabetes Res Clin Pract       Date:  2007-04-19       Impact factor: 5.602

10.  Use of Glycated Hemoglobin in the Diagnosis of Diabetes Mellitus and Pre-diabetes and Role of Fasting Plasma Glucose, Oral Glucose Tolerance Test.

Authors:  Naser Alqahtani; Waseem Abdul Ghafor Khan; Mohamed Husain Alhumaidi; Yasar Albushra Abdul Rahiem Ahmed
Journal:  Int J Prev Med       Date:  2013-09
View more
  12 in total

1.  Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices.

Authors:  Enrico Longato; Giada Acciaroli; Andrea Facchinetti; Alberto Maran; Giovanni Sparacino
Journal:  J Diabetes Sci Technol       Date:  2019-03-31

2.  Association between visit-to-visit variability of HbA1c and cognitive decline: a pooled analysis of two prospective population-based cohorts.

Authors:  Zhe-Bin Yu; Yao Zhu; Die Li; Meng-Yin Wu; Meng-Ling Tang; Jian-Bing Wang; Kun Chen
Journal:  Diabetologia       Date:  2019-09-04       Impact factor: 10.122

3.  Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c < 5.7%: a pilot study.

Authors:  Brenda Dorcely; Eliud Sifonte; Collin Popp; Anjana Divakaran; Karin Katz; Sarah Musleh; Ram Jagannathan; Margaret Curran; Mary Ann Sevick; José O Aleman; Ira J Goldberg; Michael Bergman
Journal:  Endocrine       Date:  2022-06-21       Impact factor: 3.925

4.  Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study.

Authors:  Justin B Echouffo-Tcheugui; Songzhu Zhao; Guy Brock; Roland A Matsouaka; David Kline; Joshua J Joseph
Journal:  Diabetes Care       Date:  2019-01-18       Impact factor: 19.112

5.  Effects of Acute Ingestion of Native Banana Starch on Glycemic Response Evaluated by Continuous Glucose Monitoring in Obese and Lean Subjects.

Authors:  Guadalupe Jiménez-Domínguez; Jorge L Ble-Castillo; María A Aparicio-Trápala; Isela E Juárez-Rojop; Carlos A Tovilla-Zárate; Deysi J Ble-Castillo; Carlos García-Vázquez; Viridiana Olvera-Hernández; Bedelia Pérez-Pimienta; Juan C Diaz-Zagoya; José D Mendez
Journal:  Int J Environ Res Public Health       Date:  2015-07-06       Impact factor: 3.390

6.  Slow-release carbohydrates: growing evidence on metabolic responses and public health interest. Summary of the symposium held at the 12th European Nutrition Conference (FENS 2015).

Authors:  Sophie Vinoy; Martine Laville; Edith J M Feskens
Journal:  Food Nutr Res       Date:  2016-07-04       Impact factor: 3.894

7.  Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial).

Authors:  Kristine Færch; Hanan Amadid; Lea Bruhn Nielsen; Mathias Ried-Larsen; Kristian Karstoft; Frederik Persson; Marit Eika Jørgensen
Journal:  BMJ Open       Date:  2017-06-06       Impact factor: 2.692

8.  Moods in Clinical Depression Are More Unstable than Severe Normal Sadness.

Authors:  Rudy Bowen; Evyn Peters; Steven Marwaha; Marilyn Baetz; Lloyd Balbuena
Journal:  Front Psychiatry       Date:  2017-04-12       Impact factor: 4.157

9.  Relative contributions of preprandial and postprandial glucose exposures, glycemic variability, and non-glycemic factors to HbA 1c in individuals with and without diabetes.

Authors:  Kristine Færch; Marjan Alssema; David J Mela; Rikke Borg; Dorte Vistisen
Journal:  Nutr Diabetes       Date:  2018-06-01       Impact factor: 5.097

10.  Impact of First Meal Size during Prolonged Sitting on Postprandial Glycaemia in Individuals with Prediabetes: A Randomised, Crossover Study.

Authors:  Evelyn B Parr; Brooke L Devlin; Samuel K Pinto; David W Dunstan; John A Hawley
Journal:  Nutrients       Date:  2018-06-06       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.